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Background: The aryl hydrocarbon receptor (AhR) has gradually emerged as a regulator of inflammation in the
lung and other tissues. AhR may interact with the p65-subunit of the nuclear factor (NF)-κB transcription factors, but
reported outcomes of AhR/NF-κB-interactions are conflicting. Some studies suggest that AhR possess pro-inflammatory
activities while others suggest that AhR may be anti-inflammatory. The present study explored the impact of AhR and
its binding partner AhR nuclear translocator (Arnt) on p65-activation and two differentially regulated chemokines,
CXCL8 (IL-8) and CCL5 (RANTES), in human bronchial epithelial cells (BEAS-2B).
Results: Cells were exposed to CXCL8- and CCL5-inducing chemicals, 1-nitropyrene (1-NP) and 1-aminopyrene (1-AP)
respectively, or the synthetic double-stranded RNA analogue, polyinosinic-polycytidylic acid (Poly I:C) which induced
both chemokines. Only CXCL8, and not CCL5, appeared to be p65-dependent. Yet, constitutively active unligated AhR
suppressed both CXCL8 and CCL5, as shown by siRNA knock-down and the AhR antagonist α-naphthoflavone.
Moreover, AhR suppressed activation of p65 by TNF-α and Poly I:C as assessed by luciferase-assay and
p65-phosphorylation at serine 536, without affecting basal p65-activity. In contrast, Arnt suppressed only CXCL8,
but did not prevent the p65-activation directly. However, Arnt suppressed expression of the NF-κB-subunit RelB
which is under transcriptional regulation by p65. Furthermore, AhR-ligands alone at high concentrations induced a
moderate CXCL8-response, without affecting CCL5, but suppressed both CXCL8 and CCL5-responses by Poly I:C.
Conclusion: AhR and Arnt may differentially and independently regulate chemokine-responses induced by both
inhaled pollutants and pulmonary infections. Constitutively active, unligated AhR suppressed the activation of p65,
while Arnt may possibly interfere with the action of activated p65. Moreover, ligand-activated AhR suppressed CXCL8
and CCL5 responses by other agents, but AhR ligands alone induced CXCL8 responses when given at sufficiently high
concentrations, thus underscoring the duality of AhR in regulation of inflammation. We propose that AhR-signaling
may be a weak activator of p65-signaling that suppresses p65-activity induced by strong activators of NF-κB, but that
its anti-inflammatory properties also are due to interference with additional pathways.
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The aryl hydrocarbon receptor (AhR) is a ligand-activated
transcription factor originally discovered as a receptor
for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and other
environmental pollutants, including polycyclic aromatic hy-
drocarbons (PAHs). In its classical mode of action, cytosolic
AhR activated by hydrocarbons rapidly translocates to the
nucleus where it dimerizes with the AhR nuclear transloca-
tor (Arnt). The AhR/Arnt complex binds to dioxin or xeno-
biotic response elements (DREs or XREs) in the promoter
region of target genes, such as the cytochrome P450
enzymes CYP1A1 and -1B1 [1].
It has now become evident that the AhR is also involved
in regulation of inflammation as well as a variety of other
endogenous processes. Chronic low-grade inflammation is
a common feature of a variety of multi-factorial diseases
including various pulmonary disorders [2,3]. It has been
suggested that increases in such chronic disorders at least
partly may be related to inhalation of environmental pollut-
ants, contributing to development or exacerbation of in-
flammation [4-6]. That one of the main cellular sensors of
hydrocarbons is now emerging as a regulator of innate im-
mune responses may therefore be of particular importance.
In addition, the role of AhR in inflammation does not seem
to be restricted to effects of inhaled man-made chemicals.
There seems to be a considerable cross-talk between
AhR-signaling and the nuclear factor-κB (NF-κB) family
of transcription factors [7,8]. The classical NF-κB-pathway
typically characterized by the p65/p50 dimer is central
in regulation of inflammatory responses through binding
to κB-sites in the promoter region of a variety of pro-
inflammatory genes, including several cytokines and
chemokines [7,8]. In lung cells, TCDD exposure in-
creased NF-κB activity and IL-6 expression [9]. TCDD
also induced IL-1β, IL-6 and CXCL8 (IL-8) through
AhR-mediated activation of NF-κB in rheumathoid arthritis
[10]. Furthermore, Vogel and colleagues [11,12] showed
that TCDD induced dimerization of AhR and RelB of the
alternative NF-κB pathway and up-regulation of CXCL8
through a novel RelB/AhR response element (RelBAHRE)
in macrophages and breast cancer cells [12]. Unligated AhR
has been found to dimerize with p65 and activate κB-sites
in the IL-6 and c-myc promoters [9,13], and overexpression
of constitutively activated AhR was associated with inflam-
matory skin lesions in mice [14]. In addition, the archetyp-
ical PAH benzo[a]pyrene (B[a]P) appeared to induce
CXCL8 expression through binding of AhR to consensus
XRE sites in the CXCL8 promoter [15].
In stark contrast, AhR-deficient mice displayed in-
creased NF-κB activity and inflammation in the lungs
after inhalation of lipopolysaccharide (LPS), cigarette
smoke as well as instillation of crystalline silica [16,17].
AhR knock-down also seems to cause hypersensitivity
towards systemic inflammation in mice exposed to LPSby intraperitoneal injection [18,19], and AhR deprivation
increases LPS-induced cytokine responses in various cell
types [18,20,21]. In addition, AhR-agonists such as TCDD
and β-naphthoflavone (BNF) suppressed NF-κB signaling
and cytokine responses induced by TNF-α, LPS and crystal-
line silica [17,21,22]. Thus, AhR seems to elicit both pro-
and anti-inflammatory functions and both enhance and
suppress NF-κB activity in the lung and other tissues.
We have previously found that 1-nitropyrene (1-NP),
a prominent PAH in diesel exhaust, induced a cytokine/
chemokine expression profile in human bronchial epithelial
cells (BEAS-2B) characterized by high levels of CXCL8,
whereas its amine metabolite 1-aminopyrene (1-AP)
induced a different response characterized by increased
CCL5 (RANTES) [23,24]. CXCL8 is a potent neutrophil
attractant associated with innate immune responses [25,26],
while CCL5 activates and attracts eosinophils commonly
involved in allergic reactions [27]. CXCL8 may also contrib-
ute to tumor growth [28-30], while CCL5 may induce anti-
tumor responses [31-33]. In addition to their differential
biological properties, expression of CXCL8 and CCL5 also
appear to be regulated differentially in airway epithelial cells
[34,35]. The effects of 1-NP on CXCL8 seems to involve
ROS-formation and signaling through the TACE/TGF-α/
EGFR-cascade [36-38], while the mechanisms of 1-AP
induced CCL5 are less clear. However, the chemokine re-
sponses induced by both compounds seems at least partly
to involve activation of β2-adrenergic receptors [39] (as well
as unpublished results from our lab). Due to their differen-
tial effects, the 1-NP-induced CXCL8 versus 1-AP-induced
CCL5 represented an intriguing model for studying the im-
pact of AhR and Arnt on pro-inflammatory responses.
In the present work we have explored the roles of AhR
and Arnt in the regulation of CXCL8 and CCL5 with em-
phasis on the involvement of the classical and alternative
NF-κB pathway in BEAS-2B cells. Cells were exposed
to 1-NP and 1-AP as well as polyinosinic-polycytidylic acid
(Poly I:C), a synthetic double-stranded RNA analogue
and Toll-like receptor 3 (TLR3) agonist known to induce
NF-κB signaling and both CXCL8 and CCL5 responses in
BEAS-2B cells [38]. The results suggest that the constitutive
(endogenous) activity of unligated AhR and Arnt differen-
tially suppress CXCL8 and CCL5 responses, and we propose
an explanation for how AhR may both induce and suppress
NF-κB signaling, even within the same cell type. The results
also suggest that anti-inflammatory effects of AhR necessar-
ily extend beyond interactions with the NF-kB pathway.
Results
Role of p65 in CXCL8 and CCL5 regulation in 1-NP- or
1-AP-exposed BEAS-2B cells
We have previously shown that 1-NP induces CXCL8, while
1-AP induces CCL5 in BEAS-2B cells [23,24]. As a first step,
we explored the involvement of the classical NF-κB pathways
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transfecting the cells with siRNA against p65 or non-
targeting control siRNA. The classical NF-κB pathway is gen-
erally considered necessary for transcription of CXCL8 [40].
In line with this, we found that p65 silencing completely
blocked both basal and induced CXCL8 responses (Figure 1A
and C). In contrast, p65 siRNA had little impact on, or rather
increased, the 1-AP-induced CCL5 response (Figure 1B and
D). The protein level of p65 was markedly down-regulated
in cells treated with the p65 siRNAs, confirming the
efficiency of the transfection (Figure 1E). The above results
suggest that the classical NF-κB pathway is needed for the
CXCL8 response, but not for CCL5 in our cell model.
Role of AhR and Arnt in CXCL8 and CCL5 regulation in
1-NP- or 1-AP-exposed BEAS-2B cells
As a next step we explored the roles of AhR and Arnt in
the regulation of 1-NP-induced CXCL8 and 1-AP-inducedFigure 1 P65 is required for CXCL8 but not CCL5 responses in 1-NP
siRNA against p65 (siP65) or non-targeting control siRNA (siNT), and exp
CCL5 (B) gene expression were measured after 6 h by real-time PCR. CX
by ELISA after 18 h exposure as described under “Materials and methods
The results are expressed as mean ± SEM (A/B: n = 1 (triplicate determina
different from unexposed controls; †Significantly different from cells traCCL5. Thus, BEAS-2B cells were transfected with siRNA
against AhR, Arnt or non-targeting control siRNA prior to
exposure. Silencing of both AhR and Arnt increased 1-NP-
induced CXCL8 mRNA expression after 6 h exposure and
protein release after 18 h exposure (Figure 2A and C), with
a markedly higher response in cells transfected with Arnt
siRNA. However, only silencing of AhR induced a strong in-
crease in both basal and induced CCL5 (Figure 2B and D).
In comparison, targeting Arnt resulted in a more moderate
increase in CCL5 that seemed restricted to basal and not
induced levels, as 1-AP failed to increase CCL5 release in
Arnt-depleted cells (Figure 2D). Notably, AhR silencing
increased basal levels of CCL5 but not CXCL8, indicating
that AhR regulated the two chemokines differentially. In
comparison Arnt silencing seemed to induce an increase
in basal levels of both CXCL8 and CCL5. This was con-
firmed by a more detailed examination of the effects on
basal chemokine levels (Additional file 1: Figure S1, online- or 1-AP-exposed BEAS-2B cells. Cells were transfected with
osed to 20 μM 1-NP, 1-AP or vehicle (DMSO) alone. CXCL8 (A) and
CL8 (C) and CCL5 (D) protein levels in the medium were measured
”. Efficiency of transfection was assessed by Western blotting (E).
tions); C/D: n ≥ 3; E: representative blot, n = 3). *Significantly
nsfected with non-targeting siRNA.
Figure 2 AhR and Arnt differentially regulate CXCL8 and CCL5 responses in 1-NP- or 1-AP-exposed BEAS-2B cells. Cells were transfected
with siRNA against AhR (siAHR) and Arnt (siARNT) or non-targeting control siRNA (siNT), and exposed to 20 μM 1-NP, 1-AP or vehicle (DMSO)
alone. CXCL8 (A) and CCL5 (B) gene expression were measured after 6 h by real-time PCR. CXCL8 (C) and CCL5 (D) protein levels in the medium
were measured by ELISA after 18 h exposure as described under “Materials and methods”. Efficiency of transfection was assessed by Western
blotting (E) as well as expression of CYP1A1 after 6 h exposure to 20 μM B[a]P, 1-NP and 1-AP, by real-time PCR (F). The results are expressed as
mean ± SEM (A/B/F: n = 1 (triplicate determinations); C/D: n≥ 3; E: representative blots, n ≥ 3). *Significantly different from unexposed controls;
†Significantly different from cells transfected with non-targeting siRNA.
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transfection was verified by Western blotting, showing
depletion of AhR and Arnt by their respective siRNAs
(Figure 2E). In addition, AhR and Arnt silencing also
reduced basal CYP1A1 expression and blocked B[a]P-
dependent induction of CYP1A1 (Figure 2F), which
further confirmed the efficiency of the siRNA transfections.
Having shown that AhR and Arnt depletion enhanced
CXCL8 and CCL5 responses, we next explored whether
blocking the PAH-binding site of AhR would result in
similar effects. Indeed, both 1-NP and 1-AP seem to have
the ability to bind and activate AhR in other cells types
[41,42], although they did not induce CYP1A1 in the
BEAS-2B cells (Figure 2F). Thus, to investigate whether the
suppressive effects of AhR and Arnt on CXCL8 and CCL5
were related to ligand-mediated activation, BEAS-2B cellswere treated with the AhR antagonist α-naphthoflavone
(ANF), prior to PAH exposure. Pretreatment with 0.5 μM
of ANF reduced B[a]P-induced CYP1A1 induction by
more than 50%, confirming the efficiency of the antagonist
(Figure 3A). However, in contrast to the enhanced chemo-
kine responses observed by siRNA transfection (Figure 2),
blocking the ligand-binding site of AhR with ANF did
not affect CXCL8 levels (Figure 3B), and rather decreased
1-AP-induced CCL5 (Figure 3C).
The above results suggest that AhR acts as a suppres-
sor of both 1-NP-induced CXCL8 and 1-AP-induced
CCL5, while Arnt more selectively suppresses 1-NP-
induced CXCL8 responses in BEAS-2B cells. These
effects seemed to be independent of ligand-mediated
activation of AhR, and may therefore rather be due to
basal or constitutive receptor activity. Moreover, since
Figure 3 Blocking of AhR ligand binding does not increase CXCL8 and CCL5 responses in BEAS-2B cells. Cells were incubated with
0.5 μM of the AhR antagonist α-naphtoflavone (ANF) for 30 min prior to exposure for 18 h to 20 μM B[a]P, 1-NP, 1-AP or vehicle (DMSO) alone.
CYP1A1 (A) levels were measured by real-time PCR, while CXCL8 (B) and CCL5 (C) levels in the medium were measured by ELISA as described
under “Materials and methods”. The results are expressed as mean ± SEM (A: n = 1 (triplicate determinations); B/C: n = 5). *Significantly different
from unexposed controls; †Significant effect of ANF.
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(Figure 1), suppression of CCL5 by AhR was most likely
mediated through NF-κB-independent mechanisms.
Induction of NF-κB activity by 1-NP and TNF-α, and the
roles of AhR and Arnt
Since basal and 1-NP-induced CXCL8 seemed dependent
on p65 expression, we next investigated the effect of 1-NP
on activation of NF-κB using a luciferase assay for p65
activity. In an initial screen, the pro-inflammatory cyto-
kine TNF-α used as positive control appeared to induce a
strong increase in NF-κB-driven luciferase activity
after both 6 and 16 h exposure (Figure 4A). In com-
parison, 1-NP did not affect luciferase activity at the
early time point and only induced a moderate increase after
16 h (Figure 4A). However, this effect was not statisticallyFigure 4 AhR silencing increased TNF-α-, but not 1-NP-induced p50/p65
a NF-κB-luciferase (p50/p65) reporter gene, and exposed to 1-NP or TNF-α for 6
“Materials and methods”. Cells transfected siRNAs against AhR (siAHR), Arnt (siA
NF-κB-luciferase promoter and assayed for luciferase activity after a 16 h expos
mean ± SEM (A: n = 2; B: n = 5). *Significantly different from unexposed controlsignificant in the next set of experiments (Figure 4B).
Moreover, no effect on IκB-degradation or phosphorylation
of p-p65 were observed after 2 or 4 h exposure to 1-NP or
1-AP (Additional file 2: Figure S2, online supplementary
material). Considering that 1-NP induced a marked
increase in CXCL8 mRNA expression already after 4 h
exposure (Figures 1A and 2A), it does not seem that 1-NP
mediated the CXCL8 response through activation of the
classical NF-κB pathway. Thus, p65 most likely played a
strictly permissive role in 1-NP-induced CXCL8 (Figure 1),
and that the observed effect of p65 silencing was due to
attenuation of the basal transcription factor activity. In
line with this, p65 depletion also reduced CXCL8 levels in
controls and 1-AP-exposed cells (Figure 1).
To assess any possible influence of AhR and Arnt on
p65 activity, we measured p65-induced luciferase activityreporter gene expression in BEAS-2B cells. Cells were transfected with
or 16 h (A), and assayed for luciferase activity as described under
RNT) or non-targeting control siRNA (siNT) were further transfected with
ure to 1-NP (20 μM) or TNF-α (50 ng/ml) (B). The results are expressed as
s; †Significantly different from cells transfected with non-targeting siRNA.
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to 1-NP or TNF-α. AhR silencing by siRNA did not affect
basal or 1-NP-induced p65 activity significantly (Figure 4B).
If anything, the low-level induction of p65 activity by
1-NP was rather reduced. Thus, it seems that not only
1-AP-induced CCL5, but also the 1-NP-induced CXCL8 re-
sponse was suppressed by AhR through mechanisms other
than interference with the classical NF-κB pathway. However,
AhR silencing resulted in a moderate, but statistically signifi-
cant increase in TNF-α-induced p65 activity (Figure 4B),
suggesting that the constitutive activity of AhR modestly sup-
presses the p65 signaling induced by stronger activators of
the classical NF-κB pathway. Cells transfected with Arnt
siRNA did not display any changes in luciferase activity as
compared to non-targeting control siRNA (Figure 4B).
Role of AhR and Arnt in p65 and CXCL8/CCL5 regulation
in Poly I:C-exposed BEAS-2B cells
To examine if the chemokine regulation by AhR and Arnt
were of a more general nature, we continued by exploring
their effects in cells exposed to the Toll-like receptor 3
(TLR3)-ligand Poly I:C. In agreement with previous re-
ports [43,44], Poly I:C induced strong increases in both
CXCL8 and CCL5 along with activation of the classical
NF-κB pathway, as evidenced by the degradation of IκB
and increased phosphorylation of p65 at serine 536
(Additional file 2: Figure S2, online supplementary materials).
This allowed for assessing the effects of AhR and Arnt
on CXCL8 and CCL5 responses induced by a single
compound without known affinity for the AhR or CYP-
enzymes, that unlike 1-NP and 1-AP, also activated the
classical NF-κB pathway. We thus examined the effects
of targeting p65, AhR and Arnt by siRNA in Poly I:C-
exposed cells. In line with the observed increase in
TNF-α-induced p65 activity by AhR-silencing (Figure 4B),
we found that depletion of AhR resulted in increased
Poly I:C-induced phosphorylation of p65 at serine 536
(Ser536) in BEAS-2B cells at 2 h, while Arnt depletion
did not cause any significant effects (Figure 5A and B).
This strengthens the notion that AhR suppresses acti-
vation of p65-signaling induced by strong inducers of
the classical NF-κB pathway. As in PAH-exposed cells
(Figure 1), we again observed that CXCL8, but not
CCL5, was dependent on p65 (Figure 5C and D). In
further agreement with the data obtained by 1-NP and
1-AP exposure (Figure 2), silencing of both AhR and
Arnt increased CXCL8 responses in Poly I:C-exposed
BEAS-2B cells (Figure 5E), while only AhR silencing
augmented CCL5 (Figure 5F). The effects obtained by the
custom made siRNA against AhR were confirmed by use of
commercially available siRNA (Additional file 3: Figure S3,
online supplementary materials). This fortifies the observa-
tions made by PAH treatment and suggests that AhR and
Arnt may play a general role in the regulation of CXCL8and CCL5 in BEAS-2B cells, independently of exposure.
The results further suggest that AhR may interfere with
phosphorylation of p65 at Ser536 which is considered
important for transactivation of p65 and transcription of
CXCL8 [45,46]. Moreover, as CCL5 was not affected by p65
silencing, AhR necessarily also regulated Poly I:C-induced
CCL5 expression through interactions with other pathways.
Interaction with CXCL8 and CCL5 promoters and
subcellular localization of p65, AhR and Arnt in
Poly I:C-exposed BEAS-2B cells
For a more complete understanding of the roles of p65,
AhR and Arnt in CXCL8 and CCL5 regulation, we also
assessed to what extent they interacted directly with the
NF-κB-response element containing regions of the CXCL8
and CCL5 promoters when cells were exposed to ligands.
In line with the above results, ChIP assay revealed that Poly
I:C treatment induced a strong increase in p65 binding to
the CXCL8 promoter, but not to the CCL5 promoter
(Figure 6). Moreover, we were unable to detect binding of
AhR and Arnt to the CXCL8 and CCL5 promoters by ChIP
(data not shown). Thus, neither AhR nor Arnt appeared to
suppress chemokine responses by interfering directly the
NF-κB responsive regions of the CXCL8 and CCL5 pro-
moters. Furthermore, we also assessed the subcellular
localization of p65, AhR and Arnt by immunocytochemistry.
In control cells, p65 was primarily located in the cytosol,
and translocated into the nucleus upon exposure to Poly I:C
and partly also when exposed to 1-NP (Additional file 4:
Figure S4, online supplementary materials). AhR and Arnt
on the other hand, appeared to be located both in the
cytosol and in nucleus of resting cells, and no apparent
change were observed in the sub-cellular localization upon
exposure (Additional file 4: Figure S4, online supplementary
materials). This is in line with the observation that AhR
signaling was not activated by the exposure.
Role of RelB in AhR and Arnt-mediated regulation of
CXCL8 and CCL5
RelB of the alternative (non-canonical) NF-κB pathway is a
well-known suppressor of the classical NF-κB pathway and
inflammation that itself is under transcriptional regulation by
p65 [47-49]. Therefore, if AhR or Arnt silencing enhances
p65-signaling, RelB should be increased in a similar manner
as CXCL8. Conversely, it has been proposed that the anti-
inflammatory role of AhR is related to stabilization of RelB,
resulting in a more rapid degradation of RelB in AhR-
depleted cells or tissues exposed to cigarette smoke [16,20].
We first examined the impact of AhR and Arnt silencing on
RelB expression. The results show that basal RelB levels were
markedly increased in cells transfected with Arnt, but not
AhR siRNA (Figure 7A). RelB levels were also increased in
Arnt-depleted cells exposed to Poly I:C for 2 and 4 h
(Figure 7B). In contrast, AhR silencing first increased RelB
Figure 5 AhR and Arnt differentially regulate CXCL8 and CCL5 responses as well as p65 phosphorylation in Poly I:C-exposed BEAS-2B cells.
Cells were transfected with siRNA against p65 (siP65), AhR (siAHR), Arnt (siARNT) or non-targeting control siRNA (siNT), and exposed to 10 μg/ml Poly I:C.
Intracellular protein levels of total and phospho-p65 (Ser536) as well as AhR and Arnt were detected by Western blotting after 2 and 4 h exposure, as
described under “Materials and methods”. The figure displays representative blots (A), as well as relative changes in phospho-p65 compared to total
p65 quantified by densitometric analysis of the Western blots (B). CXCL8 (C and E) and CCL5 (D and F) protein levels in the medium were measured
by ELISA after 18 h exposure, as described under “Materials and methods”. The results are expressed as mean ± SEM (n≥ 3). *Significantly different from
unexposed controls; †Significantly different from cells transfected with non-targeting siRNA.
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Arnt seemed to suppress both basal and induced RelB while
AhR more selectively suppressed only induced RelB levels.
The latter is consistent with the observation that AhR only
suppressed induced and not basal p65 activity. However, theArnt-mediated suppression of RelB suggests that Arnt may
interfere with p65-signaling despite its lack of effect on p65
activation (Figures 4 and 5). Furthermore, the results suggest
that neither AhR nor Arnt suppressed chemokine responses
by stabilizing RelB in Poly I:C-exposed BEAS-2B cells.
Figure 6 Interaction between p65 and the CXCL8 and CCL5
promoters in Poly I:C exposed BEAS-2B cells. Cells were exposed
to 10 μg/ml Poly I:C for 3 h. Interaction between p65 and the NF-κB
responsive regions of the CXCL8 and CCL5 promoters were assessed
by ChIP assay as described under Materials and methods”. Results are
expressed as fold increase compared to p65 binding to the CXCL8
promoter after adjustment for the input control (GAPDH). The results are
expressed as mean ± SEM ( n = 6). The insert figure shows the same data
set on a log-scale. *Significantly different from unexposed controls.
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Arnt-mediated transcription regulation in various ways
[11,12,16,20,49]. So, to further explore whether RelB could
be involved in AhR- or Arnt-mediated chemokine suppres-
sion, we then examined the effect of RelB silencing on
chemokine responses in 1-NP-, 1-AP- or Poly I:C-exposed
BEAS-2B cells. RelB depletion by siRNA increased CXCL8
responses (Figure 8A,C and E) but reduced CCL5 responses
(Figure 8B,D and F). Thus, the effects of RelB partly resem-
bled that of Arnt (Figures 2 and 5), by suppressing both basal
and induced CXCL8 and not CCL5. However, in contrast to
Arnt, RelB seemed to be required for CCL5 responses. The
observation that AhR in addition to suppressing CCL5
selectively suppressed induced, but not basal CXCL8 levels
(Figures 2 and 5), further suggests that AhR did not mediate
its anti-inflammatory effects through RelB.
In contrast to the effects obtained by RelB siRNA
(Figure 8), silencing its binding-partner in the alternative
NF-κB pathways, p100/p52, attenuated both CXCL8 and
CCL5 responses (Additional file 5: Figure S5A, online
supplementary materials). Moreover, neither 1-NP, 1-AP or
Poly I:C induced degradation of p100 to p52 (Additional
file 5: Figure S5B, online supplementary materials), the
hallmark of alternative NF-κB activation [50]. This suggests
that the RelB-mediated suppression of CXCL8 (Figure 8)
was independent of the alternative NF-κB pathway.
However, it is possible that the RelB-dependency of CCL5(Figure 8) may be related to some permissive role of the
alternative NF-κB pathway.
Activation of AhR by BNF suppresses Poly I:C-induced
CXCL8 and CCL5
Our present results suggest that the constitutive activity
of unligated AhR and Arnt regulate chemokine responses
through differential mechanisms. As a final step, we also
explored how ligand-mediated activation of AhR-signaling
would affect CXCL8 and CCL5 regulation. It has been re-
ported that the non-toxic AhR agonist β-naphthoflavone
(BNF) may suppress TNF-α-induced NF-κB activation and
LPS-induced cytokine responses [21,22]. Thus we exam-
ined the effect of BNF on Poly I:C-induced CXCL8 and
CCL5 in BEAS-2B cells. Pre-incubation with 1 μM BNF for
30 min prior to Poly I:C exposure for 18 h, attenuated both
Poly I:C-induced CXCL8 and CCL5 (Figure 9A and B).
This effect seem to extend to other cell types, as BNF
suppressed Poly I:C-induced chemokine responses in
A549 human alveolar type-II-like epithelial carcinoma cells
and THP-1 human leukemia monocytes (Additional file 6:
Figure S6, online supplementary materials). Of notice,
Poly I:C appeared unable to induce CXCL8-responses
in the A549 cells. We also observed that pre-incubation with
another well-known AhR-agonist, B[a]P, suppressed both
CXCL8 and CCL5 responses in BEAS-2B cells exposed to
Poly I:C or LPS (Additional file 7: Figure S7, online supple-
mentary materials). In contrast, treatment with high concen-
trations of BNF and ANF (10 and 25 μM, respectively)
alone, induced moderate two-fold increases in CXCL8 but
not CCL5 (Figure 9C and D). Therefore it seems that not
only the constitutive activity of unligated AhR, but also
ligand-mediated activation of the AhR may suppress pro-
inflammatory responses in BEAS-2B cells. These results also
show that activation of AhR by external ligands increase the
suppression of cytokine/chemokine responses compared to
the effects of unligated, constitutively active AhR. However,
in absence of other, stronger pro-inflammatory stimuli,
AhR-ligands elicited a moderat pro-inflammatory effect in
BEAS-2B cells when given at sufficiently high concentrations.
Discussion
In the present study we have compared the effects of AhR
and Arnt depletion on the classical NF-κB pathway and
expression of two differentially regulated chemokines,
CXCL8 and CCL5, in bronchial epithelial BEAS-2B cells
exposed to PAHs or the TLR3 agonist Poly I:C. The results
showed that regulation of CXCL8, but not CCL5, was
dependent on basal and/or induced p65 activity. AhR sup-
pressed both CXCL8 and CCL5 responses in BEAS-2B cells
by widely differing stimuli, while Arnt only suppressed
CXCL8. Moreover, the AhR-antagonist ANF failed to re-
produce the effects of AhR knock-down on CXCL8/CCL5
regulation. This suggests that AhR suppressed chemokine
Figure 7 Depletion of AhR and Arnt increases RelB levels in Poly I:C-exposed BEAS-2B cells. Cells were transfected with siRNA against AhR
(siAHR), Arnt (siARNT) or non-targeting control siRNA (siNT), and exposed to 10 μg/ml Poly I:C for 2 and 4 h. Intracellular protein levels of RelB
and β-actin were detected by Western blotting as described under “Materials and methods”. The figure displays representative blots of RelB levels
in unexposed cells (A) and Poly I:C-exposed cells (B). The graph depicts relative changes in RelB (B) compared to β-actin quantified by densitometric
analysis of the Western blots. The results are expressed as mean ± SEM (n = 3). *Significantly different from unexposed controls; †Significantly different
from cells transfected with non-targeting siRNA.
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likely due to the constitutive activity of unligated AhR. AhR
suppressed p65 activation induced by strong activators of
the classical NF-κB pathway, such as TNF-α and Poly I:C,
but did not affect basal p65 activity. In addition, since AhR
also suppressed CCL5, as well as the p65-independent in-
crease in CXCL8 by 1-NP (which were unable to enhance
p65 activity), the anti-inflammatory effects of AhR were ne-
cessarily not restricted to interference with NF-κB-signaling.
In contrast to AhR, Arnt seemed unable to suppress the
onset of p65 activation. Nevertheless, Arnt may still interfere
with p65 signaling through other mechanisms, possibly in
collaboration with RelB, which is a well-known suppressor
of p65 activity. A schematic presentation of the possible
roles of AhR and Arnt in suppression of CXCL8 and CCL5
in BEAS-2B cells, as discussed below, is presented in
Figure 10. In addition to the above, we also observed that
potent-AhR agonists could suppress both CXCL8 and
CCL5-responses by TLR-ligands, but given alone at suffi-
ciently high concentrations, they elicited a moderateactivation of CXCL8. Thus ligand-activated AhR appear
to possess both pro- and anti-inflammatory effects in
BEAS-2B cells.
In an elegant series of experiments Chen and colleagues
[9] showed that AhR could induce IL-6 expression and
NF-κB activity in BEAS-2B cells and H1355 human lung
adenocarcinoma cells. Overexpression of AhR resulted in
increased formation of AhR/p65-complexes that activated
κB-sites in the IL-6 promoter, while TCDD-exposure
activated the classical p65/p50-heterodimer [9]. In line
with this, we observed that high concentrations of the
AhR-ligands ANF and BNF induced a moderate increase
in CXCL8, but not the p65-independent CCL5. However,
in extension of the findings by Chen et al., [9] we further
observed that AhR in the same cell type may also possess
anti-inflammatory properties, and we propose that whether
AhR act as suppressor or inducer of inflammation largely
depends on the type and combination of stimuli. Import-
antly, our present results show that AhR depletion did not
suppress basal p65 activity or CXCL8 levels in unexposed
Figure 8 RelB suppresses CXCL8, but not CCL5, in BEAS-2B cells. Cells were transfected with siRNA against RelB (siRELB) or non-targeting
control siRNA (siNT). Transfected cells were exposed to 20 μM 1-NP, 1-AP, or vehicle (DMSO) alone (A-D) or 10 μg/ml Poly I:C or vehicle (water)
alone (E and F). CXCL8 (A) and CCL5 (B) gene expression were measured after 6 h by real-time PCR. CXCL8 (C and E) and CCL5 (D and F)
protein levels in the medium were measured by ELISA after 18 h exposure as described under “Materials and methods”. Efficiency of transfection was
assessed by Western blotting (G). The results are expressed as mean ± SEM (A/B: n = 1 (triplicate determinations); C-F: n ≥ 3; G: representative
blot, n = 3) *Significantly different from unexposed controls; †Significantly different from cells transfected with non-targeting siRNA.
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and Poly I:C was significantly enhanced. This may at
least partly, be due to AhR-mediated suppression of
p65-phosphorylation at Ser536, which is important to
CXCL8 transcription by promoting coupling of p65 to the
basal transcriptional machinery [45,46,51]. Phosphorylation
of p65 at Ser536 is mediated by Inhibitor of κB Kinases
(IKKs) [45,51]. Recent findings suggest that AhR may inter-
act directly with IKKs [52], providing a possible explanation
for the observed effects of AhR knock-down on Poly I:C-
induced Ser536 phosphorylation of p65. In addition,
the study by Chen and co-workers [9] indicates that
AhR/p65 may be a less efficient activator of κB-sites
than p65/p50 (TCDD-exposure induced more than twicethe NF-κB activity elicited by AhR-overexpression, despite
almost identical binding of p65 to the IL-6 promoter). It
is therefore conceivable that AhR/p65-dimerization may
restrict the availability of free p65 levels, thus limiting
formation of the more potent p65/p50-dimers when
cells are exposed to strong, AhR-independent, activators
of the classical NF-κB pathway such as Poly I:C, TNF-α
or LPS. A recent publication by Vogel and colleagues [53]
offers an interesting perspective to our current findings.
In their study, they found that AhR was under transcrip-
tional regulation by p65, and that LPS exposure induced
AhR expression in human dendritic cells [53]. Thus, the
suppressive effects of AhR on p65 activity may possibly be
ascribed to a negative feedback mechanism. However, in
Figure 9 AhR-activation suppresses Poly I:C-induced CXCL8 and CCL5 responses, but stimulate CXCL8 responses alone in BEAS-2B cells.
Cells were incubated with 1 μM of the AhR agonist β-naphtoflavone (BNF) for 30 min prior to exposure to 10 μg/ml Poly I:C for 18 h (A and B),
or exposed to high concentrations of ANF or BNF alone for 18 h (C and D). CXCL8 (A and C) and CCL5 (B and D) levels in the medium were
measured by ELISA as described under “Materials and methods”. The results are expressed as mean ± SEM (n = 3). *Significant increase induced
by Poly I:C; †Significant reduction induced by BNF.
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induced AhR expression in BEAS-2B cells, but rather ap-
peared to reduce the level of AhR. In any case, the scenario
of AhR as a partial NF-κB agonist acting antagonistic in
competition with stronger NF-kB activators may provide
an explanation for how different studies have observed that
AhR either induces or suppresses NF-κB signaling.
In contrast to AhR, Arnt did not seem to affect activation
of the classical NF-κB pathway as assessed by p65-luciferace
activity or p65 phosphorylation. Yet, Arnt depletion
enhanced the expression of the NF-κB target gene RelB
[47,49] in both un-stimulated and Poly I:C-exposed
BEAS-2B cells. In addition, we observed that Arnt silencing
selectively enhanced the p65-dependent chemokine CXCL8
and not the p65-independent CCL5. It seems that although
Arnt did not appear to suppress the activation of p65, it
may possibly still interfere with p65 signaling through some
other mechanisms. Of notice, we further observed that
RelB itself suppressed CXCL8 and not CCL5, in parallel
with Arnt. In addition to being transcriptionally regulated
by p65/p50, RelB is also a well-known suppressor of the
classical NF-κB pathway and inflammation that may repre-
sent a negative feed-back loop for NF-κB regulation [48,49].Interestingly, Wright and Duckett [49] showed that
Arnt facilitated RelB binding to NF-κB responsive pro-
moters preventing p65/p50-binding and suppressing
NF-κB-mediated transcription in CD30-exposed T-cells
(Karpas 299 cells). In coherence with our present findings,
they also observed that Arnt silencing increased RelB
levels in CD30-stimulated cells [49]. Whether Arnt
facilitates RelB-mediated suppression of p65 signaling
also in BEAS-2B cells is an intriguing scenario that requires
further investigation. If this is the case, the reason Arnt
depletion did not affect the NF-κB luciferase-assay is likely
that the Arnt/RelB-binding domain of wild-type NF-κB
responsive promoters was lacking in the luciferase
reporter-gene promoter.
Others have shown that increased inflammation in lungs
of LPS and cigarette smoke (CS)-exposed AhR−/− mice
were associated with a rapid loss of RelB [16]. Thus, the
anti-inflammatory role of AhR has been suggested to be
due to RelB-stabilization [20]. Our present data does not
suggest that this is the case in BEAS-2B cells. Silencing of
AhR enhanced RelB levels in BEAS-2B cells, although first
after 4 h exposure to Poly I:C. This is consistent with the
observation that AhR suppressed activation of p65 by
Figure 10 The constitutive activity of unligated AhR and Arnt differentially regulate CXCL8 and CCL5 in BEAS-2B cells. The model
summarizes the possible pathways discussed for AhR- and Arnt-mediated regulation of CXCL8 and CCL5 in BEAS-2B cells exposed to 1-NP and
1-AP (A) or Poly I:C (B). “x/X” and “y/Y” represents hitherto unidentified signaling pathways/response elements involved in regulation of CXCL8
and CCL5, respectively. The positioning of the response elements in the CXCL8 or CCL5 promoters is not meant to be representative. Moreover,
“y/Y” induced by 1-AP (A) and Poly I:C (B) are not necessarily identical and AhR may also affect other pathways involved in Poly I:C-induced
CXCL8 in addition to NF-κB (B). The suggested position and association of Arnt and RelB is partly based on findings reported by Wright and
Duckett [49]. The role of AhR and Arnt in chemokine regulation may differ in other cell types.
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we also observed that AhR and RelB were differentially
involved in regulation of CXCL8 and CCL5, which further
suggest that AhR does not mediate its effects through RelB.
Notably, although transfection with AhR siRNA did not
affect p65 activity in 1-NP-exposed cells, the AhR silencing
increased 1-NP-induced CXCL8 without affecting basalCXCL8 levels. In addition, AhR (in contrast to Arnt)
also suppressed the p65-independent CCL5 responses in
the BEAS-2B cells. This suggests that suppression of the
classical NF-κB pathway cannot be the only mechanism
for the anti-inflammatory effects of the AhR, but that at
least two additional pathways must be affected (Figure 9).
In line with this, it has been reported that the activity of
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tor protein-1 (AP-1) and CCAAT-enhancer binding protein
(C/EBP) may be affected by AhR [54,55]. Therefore it is
tempting to speculate that the differential suppression
of CXCL8 and CCL5 by AhR and Arnt in BEAS-2B cells
could be due suppression of a broader range of pro-
inflammatory pathways by AhR, or through effects on
post-transcriptional or translational processes.
The majority of the present work focused on the anti-
inflammatory role of constitutive (unligated) AhR and
Arnt activity. However, we also observed that the AhR-
agonist BNF as well as B[a]P suppressed Poly I:C-induced
CXCL8 or CCL5 responses. Thus, ligand-mediated activa-
tion increased chemokine suppression by AhR, beyond the
effects of the constitutive activity of the unligated receptor.
Similarly BNF and other AhR ligands have been reported to
suppress LPS-induced cytokine expression and inflamma-
tion, in vitro and in vivo [18,21]. Moreover, in a recent study
TCDD was found to suppress silica-induced inflamma-
tion [17]. Considering that TCDD has been reported to
induce p65/p50 through AhR [9] and that our present
CCL5-responses were unaffected by p65 depletion
(Figures 4 and 7), it seems unlikely that BNF and B[a]P
attenuated Poly I:C-induced CXCL8 and CCL5 through
suppression of NF-κB signaling in the BEAS-2B cells.
However, whether unligated and ligand-activated (i.e.
endogenously and exogenously activated) AhR sup-
press inflammation through similar pathways remains
to be clarified.
The present study was performed in BEAS-2B cells, a
common model of human bronchial epithelial cells which
has been reported to exhibit the highest homology in gene
expression pattern with primary lung cells as compared to
other established lung cell lines [56]. As any result obtained
with immortalized cell lines, generalizations should always
be interpreted with some caution. However, several in vivo
studies with AhR knock-out mice or in primary mouse
cells support the notion that AhR suppresses induction
of NF-κB activity and inflammatory reactions in differ-
ent cells and tissues [16,17,19-21]. Moreover, in control
experiments with A549 and THP-1 cells, we observed
comparable inhibition of Poly I:C-induced chemokine
responses by the AhR agonist BNF (Additional file 5:
Figure S5, online supplementary materials), further sug-
gesting that the present findings are not restricted to
the BEAS-2B cell line. However, in a recent paper, Vogel
and colleagues [57] observed that combined exposure with
TCDD enhanced the expression of IL-6, IL-10, IL-22, IL-23,
CXCL2 and CXCL3 in LPS-stimulated dendritic cells. Only
LPS-induced DC-CK1 was suppressed by TCDD exposure,
while IL-12 and TNFα responses were unaffected [57].
Whether these discrepancies with our present observations
are related to cell-specific effects or variations in effects of
AhR in different target genes remains to be clarified.Conclusion
Understanding the role of AhR and Arnt in the regulation
of inflammation may be crucial to elucidate the pro-
inflammatory effects of complex chemical mixtures, such
as air pollution which may contain a variety of organic che-
micals with varying affinity for the AhR [58]. Moreover, in-
dividual variation in AhR and Arnt expression levels appear
to be considerable [59,60] and may possibly affect suscepti-
bility towards inflammatory disease. Though it remains to
unravel the precise mechanisms by which AhR and its part-
ners modulate inflammation, our present results suggest
that depending on the type and combination of stimuli
AhR may possess both pro- and anti-inflammatory
functions, even within a single cell type. Both constitutive
and ligand-activated AhR may elicit a weak to moderate
pro-inflammatory signal, but seems to restrict activation
of p65 upon encounters with strong activators of the clas-
sical NF-κB pathway, such as Poly I:C or TNF-α. The AhR
binding partner Arnt displays a separate anti-inflammatory
role. While AhR appears to attenuate the onset of p65 ac-
tivation, including phosphorylation at Ser536, Arnt may
possibly block the access of activated p65 to kB-sites in
NF-κB-regulated promoters (Figure 10). This would fit
with the traditional perception of a differential intracellu-
lar localization of AhR and Arnt in cytosol and nucleus of
resting cells, respectively [9]. However, Arnt may also be
present in the cytosol [49], and our current findings sug-
gest that AhR and Arnt were relatively evenly distributed
across the two compartments in unstimulated BEAS-2B
cells. Finally, our results suggest that both unligated and
ligand-activated AhR also suppress pro-inflammatory re-
sponses through pathways other than NF-κB. Thus, AhR
and Arnt appear to play complex many-faceted roles in
the regulation of pro-inflammation reactions in lung cells.
Materials and methods
Reagents
Culture medium, Nutrition Mixture F12 HAM Kaigin’s
modification (F12K) was obtained from Sigma–Aldrich,
LHC-9 medium was from Invitrogen, while RPMI 1640 and
fetal bovine serum (FBS) were from Gibco BRL. Ampicillin
and fungizone were from Bristol-Myer Squibb, and
penicillin/streptomycin was from Bio Whittaker. B[a]P,
1-NP, 1-AP, α-naphthoflavone (ANF), β-naphthoflavone
(BNF), dimethyl sulphoxide (DMSO), Poly I:C-potassium
salt, antibodies against β-actin, short interfering RNA
(siRNA) against AhR (sense: GGACAAACUUUCAGUU
CUU, anti-sense: AAGAACUGAAAGUUUGUCC) and
RelB (sense: GACAAGAAAUCCACAAACA, anti-sense:
UGUUUGUGGAUUUCUUGUC) and non-targeting
control siRNA (sense: UAGCGACUAAACACAUCAA,
anti-sense: UUGAUGUGUUUAGUCGCUA) were from
Sigma-Aldrich. SiRNA against Arnt (ON-TARGET plus
Smart Pool L-007207-00-0005) was from Dharmacon RNAi
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AhR, Arnt, RelB and p52, and siRNA against p52 (sc-29409)
with corresponding non-targeting control siRNA (sc-37007)
were from Santa Cruz Biotechnology. Antibodies against
p65, phospho-p65 (Ser536), IκB, histone H1 and GAPDH,
ChIP grade antibody against p65 (D14E12), and SiRNA
against p65 (SignalSilence® NF-κB p65 siRNA I #6261) with
corresponding non-targeting control siRNA (SignalSilence®
Control siRNA #6568) were from Cell Signaling Technol-
ogy. ChIP grade antibodies against AhR (ChIP grade ab2)
and Arnt (ChIP grade ab2770) were from Abcam plc. All
other chemicals used were purchased from commercial
sources at the highest purity available.
Cell cultures
BEAS-2B cells, a SV40 hybrid (Ad12SV40) transformed
human bronchial epithelial cell line, were from European
Collection of Cell Cultures. Cells were maintained in serum-
free LHC-9 medium in collagen-coated (PureColTM,
Inamed Biomaterials) flasks. The human alveolar type-II-
like carcinoma cell line A549 and the human leukemia
monocyte cell line THP-1 were obtained from the American
Type Culture Collection (Manhasset, VA, USA). A549 cells
were cultured in F12K medium, supplemented with ampi-
cillin (100 μg/ml), penicillin/streptomycin (100 μg/ml),
fungizone (0.25 μg/ml) and 10% heat-inactivated FBS,
while THP-1 cells were cultured in RPMI 1640 medium
supplemented with 100 μg/ml gentamicin and 10% heat-
inactivated FBS fetal calf serum. Cells were cultured in a
humidified atmosphere at 37°C with 5% CO2, and pas-
saged twice per week. Prior to exposure, cells were plated
in 12-well culture dishes, grown to near confluence
and treated as described elsewhere. When used, DMSO
concentrations in all samples were below 0.5%.
Gene expression
Total RNA was isolated using Absolutely RNA Miniprep
Kit (Stratagene, La Jolla, CA, USA) and reverse transcribed
to cDNA on a PCR System 2400 (PerkinElmer) using a
High Capacity cDNA Archive Kit (Applied Biosystems).
Real-time PCR was performed using pre-designed TaqMan
Gene Expression Assays and TaqMan Universal PCR Master
Mix and run on ABI 7500 fast (Applied Biosystems).
Gene expression of CXCL8 (Hs00174103_m1), CCL5
(Hs00174575_m1) and CYP1A1 (Hs00153120_m1) were
normalized against 18S rRNA (Hs99999901_s1), and
expressed as fold change compared to untreated control
as calculated by the ΔΔCt method (ΔCt = Ct [Gene of
Interest] – Ct [18S]; ΔΔCt =ΔCt [Treated] – ΔCt [Control];
Fold change = 2 [−ΔΔCt]).
Chemokine release
Chemokine protein levels in cell-supernatants were deter-
mined by ELISA assays for CXCL8 (Human IL-8 Cytoset)and CCL5 (Human RANTES Cytoset) from Biosource
International as described elsewhere [24]. Absorbance
was measured using a plate reader (TECAN Sunrise,
Phoenix Research Products) complete with software
(Magellan V 1.10).
Gene silencing by siRNA
BEAS-2B cells were reverse-transfected with the respective
siRNAs, using HiPerFect transfection reagent according to
the Fast-Forward protocol for adherent cells recommended
by Qiagen adapted for 12-well plate format, to give a final
siRNA concentration of 10 nM and 2.75 μl of HiPerFect in
a total of 1 ml growth medium. The effectiveness of gene
silencing was monitored at 48, 72 and 96 h by measuring
protein levels by Western blotting.
NF-κB luciferase assay
Cells seeded at 55x103 cells/cm2 were transfected 24 h
later with the respective siRNAs using DharmaFECT 1
(Thermo Fischer Scientific) according to protocol. The next
day, reporter gene constructs were transiently transfected
into cells. For this, the media were changed to opti-MEM
(Gibco) containing 2.5 μl/ml of Fugene 6 (Roche), 375 ng
of a NF-kB-driven luciferase reporter vector (Stratagene ref:
219058–51) and 40 ng of a renilla reporter vector, used
as an internal control, according to the manufacturer’s
instructions. 24 h after this second transfection, cells
were exposed for 6 or 16 h to DMSO or 1-NP or TNFα.
Cell extracts were assayed for luciferase activity with a
Dual-Luciferase® Reporter assay system from Promega
according to the manufacturer’s instructions.
Immunoblotting
Total and phosphorylated protein levels were analyzed
by Western blotting as described elsewhere [61]. The
Compartment Protein Extraction Kit (BioChain Institute,
Inc.) was used for or extraction/isolation of nuclei and cyto-
sol according to producer’s recommendations. The blots
were developed and quantified using a ChemiDox™
XRS + molecular imager with Image Lab™ software,
Bio-Rad Laboratories Inc. (Hercules, CA, USA).
Immunocytochemistry
Cells were grown in X-well Tissue Culture Chambers
(Sarstedt). Effect of treatment were stopped by washing
with ice-cold PBS, and cells were fixed by incubation inn
methanol for 4 min, before incubation overnight with
antibodies against p65, AhR or Arnt (working dilution 1:
200 in PBS with 1% BSA). After washing and incubating
for 3 h with secondary antibodies conjugated with Alexa
Fluor®488 or 594, the preparations were visualized using
a Zeiss AxioObserved.Z1 equiped with an AxioCam ERc
5 s digital camera (Zeiss).
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ChIP assay was performed according to the protocol
specified by the manufacturer (HighCell# ChIP kit,
Diagenode Inc.), In brief, treated cells were collected
by trypsinisation, and DNA-protein interactions were
cross-linked with 1% formaldehyde. Chromatin shearing
was performed by sonication at 4°C with a Bioruptor® Plus
equipped with a Minichiller (Diagenode Inc.). Lysates
were centrifuged, and aliquots (1%) of the supernatants
were collected for input control, while the remaining
supernatants were incubated overnight (at 4°C) with
magnetic beads coated with ChIP grade antibodies
against p65, AhR or Arnt. DNA was isolated from the
collected precipitates after reversal of the cross-linking
by incubation for 15 min at 55°C. Real-time PCR were
performed using primer sets for human CXCL8 and
CCL5 promoter regions containing NF-κB response
elements [62,63]. The sequences of primers used for ChIP
assay were as follows: human CXCL8 sense 5’-AGTGTGA
TGACTCAGGTTTGCCCT-3’ and anti-sense 5’-AAGCT
TGTGTGCTCTGCTGTCTCT-3’; human CCL5 promoter
sense 5’-GGGAAGAAGATTGCCTAAAC-3’ and antisense
5’-TGTGGAAATCAAAGGGACAG-3’.
Statistical analysis
Statistical significance was evaluated by GraphPad Prism
software (GraphPad Software Inc., San Diego, CA, USA),
using analysis of variance (ANOVA) with Bonferroni
post-test.
Additional files
Additional file 1: Figure S1. AhR, Arnt, p65 and RelB differentially
regulate basal CXCL8 andCCL5 levels in BEAS-2B cells. Cells were
transfected with siRNA against AhR (siAHR), Arnt (siARNT), p65 (siP65),
RelB (siRELB) or non-targeting control siRNA (siNT). Basal levels of CXCL8
(A, C and E) and CCL5 (B, D and F) protein levels in the medium
(produced over a period of 18 h) were measured by ELISA as described
under “Materials and methods”. The results are expressed as mean ± SEM
(n ≥6). *Significantly different from cell transfected with non-targeting siRNA.
Additional file 2: Figure S2. Poly I:C induce both CXCL8 and CCL5
responses and mediates IκB degradation and p65 phosphorylation in
BEAS-2B cells. Cells were exposed different concentrations of Poly I:C for
18 h, and CXCL8 (A) and CCL5 (B) levels in the medium were measured
by ELISA as described under “Materials and methods”. Subsequently, cells
were exposed to 20 μM 1-NP, 1-AP or 10 μg/ml of Poly I:C for 2 and 4 h
(n = 2). Intracellular protein levels of IκB, β-actin, p65 and phosphor-p65
(Ser536) were detected by Western blotting. The figure displays representative
blots as well as changes in IκB and phospho-p65 (p-p65) relative to β-actin or
total p65, respectively, as quantified by densitometric analysis of the Western
blots. The results are expressed as mean ± SEM (n = 2).
Additional file 3: Figure S3 AhR suppress CXCL8 and CCL5 responses
in Poly I:C-exposed BEAS-2B cells. Cells were transfected with commercially
available siRNA (Dharmacon RNAi Technologies, Thermo Fischer Scientific)
against AhR (siAHR; ON-TARGET plus Smart Pool L-004990-00) or non-targeting
control siRNA (siNT; ON-TARGET Control Pool D-001810-10-05), and exposed
to 10 μg/ml Poly I:C. CXCL8 (A) and CCL5 (B) protein levels in the
medium were measured by ELISA after 18 h exposure, as described
under “Materials and methods”, and expressed as fold increasecompared to untreated controls transfected with siNT. The results are
expressed as mean ± SEM (n = 2-3).
Additional file 4: Figure S4. Sub-cellular localization of p65, AhR and
Arnt in 1-NP and Poly I:C exposed BEAS-2B cells. Cells were exposed to
1-NP (20 μM) or Poly I:C (10 μg/ml) for 2.5 h. Sub-cellular localization of
p65, AhR and Arnt were detected by immunocytochemistry with specific
antibodies, as described under “Materials and methods”.
Additional file 5: Figure S5. Characterization of the role of alternative
NF-κB signaling in CXCL8 and CCL5 responses in BEAS-2B cells. Cells were
transfected with siRNA against p100/p52 (siP52) or non-targeting control
siRNA (siNT), and exposed to 20 μM 1-NP, 1-AP or 10 μg/ml Poly I:C for
18 h. CXCL8 (A) and CCL5 (B) levels in the medium were measured by ELISA
as described under “Materials and methods”. Efficiency of transfection with
siP52 was assessed by Western blotting (C). Subsequently, non-transfected
cells were exposed to 20 μM 1-NP, 1-AP or 10 μg/ml of Poly I:C for 2
and 4 h. Intracellular protein levels of p100, p52 and β-actin were detected
by Western blotting (D). The figure presents results obtained from 1
experiment.
Additional file 6: Figure S6. AhR-activation suppresses Poly I:C-induced
chemokine responses in A549 and THP-1 cells. A549 (A and C) and
THP-1 (B and D) cells were incubated with 1 μM of the AhR agonist
β-naphtoflavone (BNF) for 30 min prior to exposure to 10 μg/ml
Poly I:C for 18 h. CXCL8 (A and B) and CCL5 (C and D) levels in the
medium were measured by ELISA as described under “Materials and
methods”. *Significant increase induced by Poly I:C; †Significant
reduction induced by BNF. The results are expressed as mean ± SEM
(1 experiment performed in triplicates).
Additional file 7: Figure S7. Pre-treatment with B[a]P suppress LPS
and Poly I:C induced chemokine responses in BEAS-2B cells. Cells were
incubated with 25 μM B[a]P for 2 h or 24 h prior to exposure to 10 μg/ml
LPS or Poly I:C for 18 h. CXCL8 (A) and CCL5 (B) levels in the medium were
measured by ELISA as described under “Materials and methods”. The results
are expressed as mean ± SEM (n = 2).Competing interests
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